Cost–Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn’s Disease
Matthijs Versteegh(Huygens Institute for History and Culture of the Netherlands), Peter J. Wahab, Sabine Grimm(Maastricht University Medical Centre), Iñigo Bermejo(Maastricht University Medical Centre), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Simone Huygens, Fiona van Schaik, Marieke Pierik(Maastricht University Medical Centre)
Cited by 0
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252